Earlier genetic testing predicts bilateral mastectomy in young BRCA carriers
1. Across two decades, utilization of bilateral mastectomy increased among BRCA carriers 40 years old or younger with early breast ...
Tag: genomics
Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory
1. Roche has launched one of the largest artificial intelligence infrastructures in the pharmaceutical industry, powered by over 3,500 NVIDIA ...
2MM: AI Roundup – Roche and NVIDIA’s AI drug discovery factory and surgical robotics foundation model, Amazon’s nationwide health AI expansion, and Brown’s AI therapy ethics warning [March 2026]
Roche and NVIDIA deploy the pharmaceutical industry's largest AI factory A major leap in computational drug development has emerged with ...
Merck and Mayo Clinic launch AI-driven precision medicine lab
1. Merck and Mayo Clinic have launched a strategic collaboration to integrate multimodal clinical data with AI to accelerate drug ...
Genomic screening for hereditary conditions is cost-effective in young adults
1. In this decision analysis model, population screening for three common hereditary conditions was cost-effective in adults younger than 40. ...
Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting
1. In a prospective implementation trial, more than 400 infants were tested for the MT-RNR1 m.1555A>G variant using a point-of-care ...
Identification of a genetic susceptibility locus in patients with severe Covid-19
1. A 6-gene cluster at the locus 3p21.31 was determined to be related to Covid-19 susceptibility. 2. The ABO blood-group ...
Electronic health record clinical and genomic data provides relevant insights for non-small cell lung cancer
1. In patients with non-small cell lung cancer (NSCLC), an analysis of clinical and genomic data from routine care replicated ...
Elevated FGF-23 associated with recurrent cardiovascular events after acute coronary syndrome
1. Elevated FGF-23 concentration was associated with increased risk of adverse cardiovascular (CV) outcomes, including CV death and heart failure ...
Few patients report results of personal genomic testing to healthcare providers
1. In this prospective study of patient attitudes towards personal genomic testing results, only 35% of patients discussed it with ...
